Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

Novo Nordisk A/S' Q1 earnings reveal strong growth in semaglutide-driven sales despite a slight revenue miss. Learn more ...

Understand how semaglutide shows strong benefits in MASH treatment, improving liver health and reducing weight.

Unblinded safety data from Phase 2b QUALITY study expected in the second quarter of calendar 2025 -- --Topline efficacy and safety data for Phase 2b extension maintenance study expected in the second ...

Against increasing use of weight loss jabs, Weight Watchers has filed for bankruptcy. Writer Daisy Buchanan reflects on her ...

Hims & Hers achieved 136% YoY subscriber growth and unveiled ambitious 2030 goals. Discover how precision medicine drives ...

Semaglutide is the key component of weight loss and diabetes drugs like Ozempic and Wegovy, and an international team of ...

Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

The metabolic effects of weight management medicines extend beyond appetite regulation. Still, with more questions about ...

Ozempic is hailed as a miracle drug by some people using it to lose weight, however, it isn't suitable for everyone and can ...